| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $200.1M | +51.7% | +27.6% |
| R&D Expense | $17.6M | +3.2% | +5.7% |
| SG&A Expense | $36.0M | +19.3% | +15.9% |
| Operating Income | $32.3M | +458.2% | +59.1% |
| Interest Expense | $1.1M | +0.0% | +1000.0% |
| Pre-tax Income | $31.2M | +720.8% | +2.1% |
| Income Tax | $1.6M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $354.9M | +42.1% | -37.2% |
| Short-term Investments | $22.4M | -8.6% | -80.7% |
| Accounts Receivable | $40.4M | +35.9% | +46.7% |
| Current Assets | $606.1M | +35.1% | -30.8% |
| Total Assets | $1.26B | +13.1% | +1.6% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $95.3M | — | — |
| Capital Expenditures | $960K | — | — |
| Investing Cash Flow | -$191.2M | — | — |
| Financing Cash Flow | -$53.9M | — | — |
| Free Cash Flow | $94.3M | — | — |
| -77.5% |
| +118.8% |
| Net Income | $29.6M | +346.8% | -23.8% |
| EPS (Basic) | $0.24 | +340.0% | -22.6% |
| EPS (Diluted) | $0.23 | +330.0% | -23.3% |
| $395.9M |
| +64.8% |
| +5.5% |
| Long-term Debt | $15.0M | -75.0% | — |
| Total Liabilities | $430.7M | +33.8% | +8.6% |
| Stockholders' Equity | $829.1M | +4.6% | -1.7% |